Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors (Q45827732)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 December 2012

edit

Language	Label	Description	Also known as
English	Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors	scientific article published on 6 December 2012

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

title

Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

main subject

endothelium

0 references

bevacizumab

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

Daniele Veritti

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

Valentina Sarao

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

Paolo Lanzetta

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

publication date

6 December 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

published in

Journal of Ocular Pharmacology and Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

page(s)

437-441

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

Identifiers

DOI

10.1089/JOP.2012.0173

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

PubMed publication ID

23215753

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23215753

retrieved

16 December 2017

reference URL

http://europepmc.org/abstract/MED/23215753

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45827732&oldid=2084830975"